ZhuZhou QianJin PharmaceuticalLtd Yönetim

Yönetim kriter kontrolleri 3/4

ZhuZhou QianJin PharmaceuticalLtd's CEO is Zhiyong Chen, appointed in Jun 2023, has a tenure of 1.42 years. directly owns 0.018% of the company’s shares, worth CN¥836.33K. The average tenure of the management team and the board of directors is 4.3 years and 2.6 years respectively.

Anahtar bilgiler

Zhiyong Chen

İcra Kurulu Başkanı

CN¥915.2k

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	1.4yrs
CEO sahipliği	0.02%
Yönetim ortalama görev süresi	4.3yrs
Yönetim Kurulu ortalama görev süresi	2.6yrs

Son yönetim güncellemeleri

Recent updates

CEO

Zhiyong Chen (47 yo)

1.4yrs

Görev süresi

CN¥915,200

Tazminat

Mr. Zhiyong Chen is General Manager of ZhuZhou QianJin Pharmaceutical Co.,Ltd from June 20, 2023. He was Deputy General Manager of ZhuZhou QianJin Pharmaceutical Co.,Ltd from November 28, 2014 to December...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Zhiyong Chen	General Manager	1.4yrs	CN¥915.20k	0.018% CN¥ 836.3k
Aiwei Xie	Deputy GM	20.3yrs	CN¥848.30k	0.028% CN¥ 1.3m
Yun Gong	Deputy General Manager	no data	CN¥325.80k	0.011% CN¥ 514.5k
Yunjiao Ouyang	Deputy General Manager	no data	CN¥336.00k	0.011% CN¥ 514.5k
Yihua Peng	Financial Controller and Deputy General Manager	no data	CN¥325.00k	0.011% CN¥ 514.5k
Li Zhu	Board secretary	4.3yrs	CN¥612.50k	0.028% CN¥ 1.3m

4.3yrs

Ortalama Görev Süresi

47yo

Ortalama Yaş

Deneyimli Yönetim: 600479's management team is considered experienced (4.3 years average tenure).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Aiwei Xie	Deputy GM	9.5yrs	CN¥848.30k	0.028% CN¥ 1.3m
Shun Jian	Chairman	8.5yrs	CN¥1.17m	Veri yok
Shuyong Zhou	Director	2.6yrs	Veri yok	Veri yok
Yan Zeng	Director	2.2yrs	Veri yok	Veri yok
Jun Chen	Director	less than a year	Veri yok	Veri yok

2.6yrs

Ortalama Görev Süresi

53yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 600479's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.

ZhuZhou QianJin PharmaceuticalLtd Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

ZhuZhou QianJin Pharmaceutical Co.,Ltd, Annual General Meeting, May 21, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.12 (vs CN¥0.19 in 3Q 2023)

ZhuZhou QianJin Pharmaceutical Co.,Ltd to Report Q3, 2024 Results on Oct 30, 2024

Investor sentiment improves as stock rises 19%

Second quarter 2024 earnings released: EPS: CN¥0.17 (vs CN¥0.17 in 2Q 2023)

Now 20% undervalued after recent price drop

ZhuZhou QianJin Pharmaceutical Co.,Ltd to Report First Half, 2024 Results on Aug 28, 2024

Dividend of CN¥0.35 announced

First quarter 2024 earnings released: EPS: CN¥0.11 (vs CN¥0.10 in 1Q 2023)

Full year 2023 earnings released: EPS: CN¥0.76 (vs CN¥0.71 in FY 2022)

ZhuZhou QianJin Pharmaceutical Co.,Ltd, Annual General Meeting, May 21, 2024

ZhuZhou QianJin Pharmaceutical Co.,Ltd to Report Q1, 2024 Results on Apr 30, 2024

Full year 2023 earnings released: EPS: CN¥0.74 (vs CN¥0.71 in FY 2022)

ZhuZhou QianJin Pharmaceutical Co.,Ltd to Report Fiscal Year 2023 Results on Apr 12, 2024

Third quarter 2023 earnings released: EPS: CN¥0.19 (vs CN¥0.22 in 3Q 2022)

ZhuZhou QianJin Pharmaceutical Co.,Ltd to Report Q3, 2023 Results on Oct 28, 2023

Second quarter 2023 earnings released: EPS: CN¥0.17 (vs CN¥0.17 in 2Q 2022)

Full year 2022 earnings released: EPS: CN¥0.71 (vs CN¥0.72 in FY 2021)

Now 20% undervalued

Now 20% undervalued

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.17 (vs CN¥0.20 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.17 (vs CN¥0.16 in 2Q 2021)

Investor sentiment improved over the past week

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Less than half of directors are independent

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.20 (vs CN¥0.20 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.16 (vs CN¥0.10 in 2Q 2020)

Full year 2020 earnings released: EPS CN¥0.71 (vs CN¥0.70 in FY 2019)

Full year 2020 earnings released: EPS CN¥0.71

New 90-day low: CN¥8.35

New 90-day low: CN¥8.69

Third quarter earnings released

ZhuZhou QianJin Pharmaceutical Co.,Ltd to Report Q3, 2020 Results on Oct 30, 2020

New 90-day low: CN¥8.95

New 90-day low: CN¥9.12

First half earnings released

New 90-day high - CN¥10.27

ZhuZhou QianJin Pharmaceutical Co.,Ltd to Report First Half, 2020 Results on Aug 28, 2020

CEO

Görev süresi

Tazminat

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş